NVCT Stock-Based Compensation
Nuvectis Pharma Inc · Stock-Based Compensation
NVCT Stock-Based Compensation
Latest reported$6.49Mperiod ending
NVCT TTM Stock-Based Comp ($1.89M → $6.49M)
TTM stock-based compensation
High-resolution chart · PNG
NVCT stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 6,492,000 | |
| 6,514,000 | |
| 6,032,000 | |
| 5,697,000 | |
| 5,399,000 | |
| 4,930,000 | |
| 4,858,000 | |
| 4,937,000 | |
| 4,911,000 | |
| 4,599,000 | |
| 4,705,000 | |
| 3,967,000 | |
| 3,393,000 | |
| 2,953,000 | |
| 1,707,000 | |
| 1,410,000 | |
| 987,000 | |
| 2,048,000 | |
| 1,892,000 |